Functional neuroimaging in adults;L'imagerie fonctionnelle chez l'adulte

Revue Neurologique

Volumn 160, Issue 5 SUPPL., 2004, Pages

  Ryvlin, P ^a   Mauguiere F ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Epilepsy; FDG; fMRI; Imaging; MRI; PET; SPECT; Surgery

Indexed keywords

CARBON 11; FLUMAZENIL; FLUORODEOXYGLUCOSE F 18; METHIONINE; N METHYLTRYPTOPHAN; ANTICONVULSIVE AGENT; CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN MAPPING; CONFERENCE PAPER; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; HEMISPHERIC DOMINANCE; HUMAN; LANGUAGE; MEMORY; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG RESISTANCE; FOCAL EPILEPSY; LANGUAGE TEST; MEMORY DISORDER; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PREOPERATIVE CARE; REVIEW; SCINTISCANNING; TEMPORAL LOBE;

ADULT; ANTERIOR TEMPORAL LOBECTOMY; ANTICONVULSANTS; CARBON RADIOISOTOPES; COMBINED MODALITY THERAPY; DOMINANCE, CEREBRAL; DRUG RESISTANCE; EPILEPSIES, PARTIAL; EPILEPSY, TEMPORAL LOBE; FLUMAZENIL; FLUORODEOXYGLUCOSE F18; HUMANS; LANGUAGE TESTS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MEMORY DISORDERS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 4544261226     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (103)

1. ARNOLD S, BERTHELE A, DRZEZGA A, et al. (2000). Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia. Epilepsia, 41: 818-824.
2. ASANO E, CHUGANI DC, MUZIK O, et al. (2000). Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology, 54: 1976-1984.
3. BOUILLERET V, DUPONT S, SPELLE L, BAULAC M, SAMSON Y, SEMAH F. (2002). Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol, 5: 202-208.
4. BOUILLERET V, NEHLIG A, MARESCAUX C, NAMER IJ. (2000) Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy. Epilepsia, 41: 642-650.
5. BOUILLERET V, VALENTI MP, HIRSCH E, SEMAH F, NAMER IJ. (2002). Correlation between PET and SISCOM in temporal lobe epilepsy. J Nucl Med, 43: 991-998.
6. BOUSSION N, RYVLIN P, ISNARD J, HOUZARD C, MAUGUIERE F, CINOTTI L. (2000). Towards an optimal reference region in single-photon emission tomography difference images in epilepsy. Eur J Nucl Med, 27: 155-160.
7. BURDETTE DE, SAKURAI SY, HENRY TR, et al. (1995) Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology, 45: 934-941.
8. CASSE R, ROWE CC, NEWTON M, BERLANGIERI SU, SCOTT AM. (2002). Positron emission tomography and epilepsy. Mol Imaging Biol, 4: 338-351.
9. CENDES F, ANDERMANN F, DUBEAU F, MATTHEWS PM, ARNOLD DL. (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology, 49: 1525-1533.
10. CHANG DJ, ZUBAL IG, GOTTSCHALK C, et al. (2002). Comparison of statistical parametric mapping and SPECT difference imaging in patients with temporal lobe epilepsy. Epilepsia, 43: 68-74.
11. CHASSOUX F, SEMAH F, BOUILLERET V, et al. (2004). Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain, 127: 164-174.
12. CHOI D, NA DG, BYUN HS, et al. (1999). White-matter change in mesial temporal sclerosis: correlation of MRI with PET, pathology, and clinical features. Epilepsia, 40: 1634-1641.
13. CHOI JY, KIM SJ, HONG SB, SEO DW, HONG SC, KIM BT, KIM SE. (2003) extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging, 30: 581-587.
14. CHUGANI DC, CHUGANI HT, MUZIK O, et al. (1998). Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L- tryptophan positron emission tomography. Ann Neurol, 44: 858-866.
15. DEBETS RM, SADZOT B, VAN ISSELT JW, et al. (1997) Is 11C-Flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatr, 62: 141-150.
16. DIEHL B, LAPRESTO E, NAJM I, et al. (2003). Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia. Epilepsia, 44: 559-564.
17. DRZEZGA A, ARNOLD S, MINOSHIMA S, et al. (1999). 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. May, 40: 737-46.
18. DUPONT S, SEMAH F, CLEMENCEAU S, ADAM C, BAULAC M, SAMSON Y. (2000). Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy: a study using positron emission tomography with 18fluorodeoxyglucose. Arch Neurol, 57: 1331-1336.
19. DUPONT S, VAN DE MOORTELE PF, SAMSON S, et al. (2000) Episodic memory in left temporal lobe epilepsy: a functional MRI study. Brain, 23: 1722-1732.
20. DUPONT S, SEMAH F, BAULAC M, SAMSON Y. (1998). The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-PET study. Neurology, 51: 1289-1292.
21. DUPONT S, BOUILLERET V, HASBOUN D, SEMAH F, BAULAC M. (2003). Functional anatomy of the insula: new insights from imaging. Surg Radiol Anat, 25: 113-119.
22. ENGEL JJR, KUHL DE, PHELPS ME, MAZZIOTTA JC. (1982a). Interictal cerebral glucose metabolism in partial epilepsy and its relation to E.E.G changes. Ann Neurol, 12: 510-517.
23. FEDI M, REUTENS DC, ANDERMANN F, et al. (2003). Alpha-[11C]-Methyl-L- tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res, 52: 203-213.
24. FEDI M, REUTENS D, OKAZAWA H, et al. (2001). Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology, 57: 1629-1636.
25. FERNANDEZ G, SPECHT K, WEIS S, et al. (2003). Intrasubject reproducibility of presurgical language lateralization and mapping using fMRI. Neurology, 60: 969-975.
26. FOLDVARY N, LEE N, HANSON MW, COLEMAN RE, et al. (1999). Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobeepilepsy. Epilepsia, 40: 26-29.
27. GAILLARD WD, FAZILAT S, WHITE S, et al. (1995a) Interictal metabolism and blood flow are uncouples in temporal lobe cortex of patients with complex partial seizures. Neurology, 45: 1841-1847.
28. GRIFFITH HR, PERLMAN SB, WOODARD AR, et al. (2000) Preoperative FDG-PET temporal lobe hypometabolism and verbal memory after temporal lobectomy. Neurology, 54: 1161-1165.
29. HAMMERS A, KOEPP MJ, LABBE C, BROOKS DJ, THOM M, CUNNINGHAM VJ, DUNCAN JS. (2001). Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology, 56: 897-906.
30. HAMMERS A, KOEPP MJ, HURLEMANN R, THOM M, RICHARDSON MP, BROOKS DJ, DUNCAN JS. (2002). Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain, 125: 2257-2271.
31. HAMMERS A, KOEPP MJ, HURLEMANN R, THOM M, RICHARDSON MP, BROOKS DJ, DUNCAN JS. (2002). Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain, 125: 2257-2271.
32. HAMMERS A, KOEPP MJ, RICHARDSON MP, HURLEMANN R, BROOKS DJ, DUNCAN JS. (2003). Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain, 126: 1300-1318.
33. HENRY TR, VAN HEERTUM RL. (2003). Positron emission tomography and single photon emission computed tomography in epilepsy care. Semin Nucl Med, 33: 88-104. Review.
34. HONG SB, ROH SY, KIM SE, SEO DW. (2000) Correlation of temporal lobe glucose metabolism with the Wada memory test. Epilepsia, 41: 1554-1559.
35. HOLMES MD, KELLY K, THEODORE WH. (1988). Complex partial seizures. Correlation of clinical and metabolic features. Arch Neurol, 45: 1191-1193.
36. HONG SB, HAN HJ, ROH SY, SEO DW, KIM SE, KIM MH. (2002). Hypometabolism and interictal spikes during positron emission tomography scanning in temporal lobe epilepsy. Eur Neurol, 48: 65-70.
37. HUGG JW, KUZNIECKY RI, GILLIAM FG, MORAWETZ RB, FRAUGHT RE, HETHERINGTON HP. (1996) Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol, 40: 236-239.
38. JANSZKY J, HOLLO A, BARSI P, RASONYI G, EROSS L, KALOCZKAI A, HALASZ P. (2002). Misleading lateralization by ictal SPECT in temporal lobe epilepsy-a case report. Epileptic Disord, 4: 19-62.
39. JUHASZ C, CHUGANI DC, MUZIK O, WATSON C, SHAH J, SHAH A, CHUGANI HT. (2000). Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? Ann Neurol, 48: 88-96.
40. JUHASZ C, CHUGANI DC, MUZIK O, WATSON C, SHAH J, SHAH A, CHUGANI HT. (2000). Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology, 55: 825-835.
41. JUHASZ C, CHUGANI DC, MUZIK O, SHAH A, SHAH J, WATSON C, CANADY A, CHUGANI HT. (2001). Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology, 56: 1650-1658.
42. JUHASZ C, CHUGANI DC, MUZIK O, et al. (2003). Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children withintractable epilepsy. Neurology, 60: 960-968.
43. KAHANE P, MERLET I, GRÉGOIRE MC, MUNARI C, PERRET J, MAUGUIÈRE F. (1999). An H(2) (15)O-PET study of cerebral flow changes during focal epileptic discharges induced by intracerebral electrical stimulation. Brain, 122: 1851-1865.
44. KAHANE P, ISNARD J, HUFFMAN D, GUÉNOT M, et al. (2001). Temporal plus epilepsies I: Prevalence in epilepsy surgery patients. Epilepsia, 42: 192.
45. KAMINSKA A, CHIRON C, VILLE D, et al. (2003). Ictal SPEGT in children with epilepsy: comparison with intracranial EEG and relation to postsurgical outcome. Brain, 126: 248-260.
46. KANG KW, LEE DS, CHO JH, LEE JS, YEO JS, LEE SK, CHUNG JK, LEE MC. (2001). Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas. Neuroimage, 14: 1-6.
47. KIM YK, LEE DS, LEE SK, CHUNG CK, CHUNG JK, LEE MC. (2002). (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med, 43: 1167-1174.
48. KNOWLTON RC, LAXER KD, KLEIN G, et al. (2001). In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology, 57: 1184-1190.
49. KNOWLTON RC, ABOU-KHALIL B, SAWRIE SM, MARTIN RC, FAUGHT RE, KUZNIECKY RI. (2002). In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch Neurol, 59: 1882-1886.
50. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, Duncan JS. (1996). Cerebral benzodiazepine receptors in hippocampal sclerosis: An objective in vivo analysis. Brain, 119: 1677-1687.
51. KOEPP MJ, HAMMERS A, LABBE C, WOERMANN FG, BROOKS DJ, DUNCAN JS. (2000). 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology, 54: 332-9.
52. KOUTROUMANIDIS M, BINNIE CD, ELWES RD, et al.(1998). Interictal regional slow activity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications. J Neurol Neurosurg Psychiatry, 65: 170-176.
53. KOUTROUMANIDIS M, HENNESSY MJ, SEED PT, et al. (2000). Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology, 54: 1811-1821.
54. KUBU CS, GIRVIN JP, MCLACHLAN RS, PAVOL M, HARNADEK MC. (2000). Does the intracarotid amobarbital procedure predict global amnesia after temporal lobectomy? Epilepsia, 41: 1321-1329.
55. LAMUSUO S, JUTILA L, YLINEN A, et al. (2001). [18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol, 58: 933-939.
56. LAMUSUO S, PITKANEN A, JUTILA L, et al. (2000). [11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology, 54: 2252-2260.
57. LAMUSUO S, FORSS N, RUOTTINEN HM, et al. (1999). [18F]FDG-PET and whole-scalp MEG localization of epileptogenic cortex. Epilepsia, 40: 921-930.
58. LEE JD, KIM HJ, LEE BI, KIM OJ, JEON TJ, KIM MJ. (2000). Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med, 27: 1658-1665.
59. LEE SK, LEE DS, YEO JS, et al. (2002). FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy. Epilepsia, 43: 1032-1038.
60. LEE SK, YUN CH, OH JB, et al. (2003). Intracranial ictal onset zone in nonlesional lateral temporal lobe epilepsy on scalp ictal EEG. Neurology, 61: 757-764.
61. LEE DS, LEE JS, KANG KW, JANG MJ, LEE SK, CHUNG JK, LEE MC. (2001). Disparity of perfusion and glucose metabolism of epileptogenic zones in temporal lobe epilepsy demonstrated by SPM/SPAM analysis on 15O water PET, [18F]FDG-PET, and [99mTc]-HMPAO SPECT. Epilepsia, 42: 1515-1522.
62. LEE SK, YUN CH, OH JB, et al. (2003). Intracranial ictal onset zone in nonlesional lateral temporal lobe epilepsy on scalp ictal EEG. Neurology, 61: 757-764.
63. LEIDERMAN DB, BALISH M, SATO S, KUFTA C, REEVES P, GAILLARD WD, THEODORE WH. (1992). Comparison of PET measurements of cerebral blood flow and glucose metabolism for the localization of human epileptic foci. Epilepsy Res, 13: 153-157.
64. LEWIS PJ, SIEGEL A, SIEGEL AM, et al. (2000). Does performing image registration and subtraction in ictal brain SPECT help localize neocortical seizures? J Nucl Med, 41: 1619-1626.
65. LI LM, CENDES F, ANTEL SB, et al. (2000). Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol. 47: 195-200.
66. LUCIGNANI G, TASSI L, FAZIO F, et al. (1996). Double-blind stereo-EEG and FDG PET study in severe partial epilepsies: are the electric and metabolic findings related? Eur J Nucl Med, 23: 1498-1507.
67. MAEHARA T, NARIAI T, ARAI N, et al. (2004). Usefulness of [11C]Methionine PET in the Diagnosis of Dysembryoplastic Neuroepithelial Tumor with Temporal Lobe Epilepsy. Epilepsia, 45: 41-45.
68. MANNO EM, SPERLING MR, DING X, JAGGI J, ALAVI A, O'CONNOR MJ, REIVICH M. (1994). Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology, 44: 2331-2336.
69. MERLET I, GARCIA-LARREA L, GRÉGOIRE MC, LAVENNE F, MAUGUIÈRE F. (1996) Source propagation of interictal spikes in temporal lobe epilepsy. Correlations between spike dipole modelling and [18F]fluorodeoxyglucose PET data. Brain, 119: 377-392.
70. NAGY F, CHUGANI DC, JUHASZ C, et al. (1999). Altered in vitro and in vivo flumazenil binding in human epileptogenic neocortex. J Cereb Blood Flow Metab, 19: 939-947.
71. NATSUME J, KUMAKURA Y, BERNASCONI N, et al. (2003). Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology, 60: 756-761.
72. O'BRIEN TJ, SO EL, MULLAN BP, et al. (2000). Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome. Neurology, 55: 1668-1677.
73. PFUND Z, CHUGANI DC, JUHASZ C, et al. (2000). Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. J Cereb Blood Flow Metab, 20: 871-878.
74. PLOTKIN M, AMTHAUER H, MERSCHHEMKE M, et al. (2003). Use of statistical parametric mapping of (18) F-FDG-PET in frontal lobe epilepsy. Nuklearmedizin, 42: 190-196.
75. POZO M, PASCAU J, ROJO P, MALDONADO A, GONZALEZ F, DESCO M, SOLA R. (2000). 19. Correlation between FDG PET data and EEG dipole modeling. Clin Positron Imaging, 3: 173.
76. RADTKE RA, HANSON MW, HUFFMAN JM, et al. (1993). Temporal lobe hypometabolism on PET: Predictor of seizure control after temporal lobectomy. Neurology, 43: 1088-1092.
77. RUTTEN GJ, RAMSEY NF, VAN RIJEN PC, NOORDMANS HJ, VAN VEELEN CW. (2002). Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol, 51: 350-360.
78. RYVLIN P, MAUGUIERE F, SINDOU M, FROMENT JC, CINOTTI L. (1995) Interictal cerebral metabolism and epilepsy in cavernous angiomas. Brain, 118: 677-687.
79. RYVLIN P, BOUVARD S, LE BARS D, et al. (1998). Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain, 727, pp. 2067-2081.
80. RYVLIN P, BOUVARD S, LE BARS D, MAUGUIÈRE F. (1999). Transient and falsely lateralizing flumazenil-PET asymmetries in temporal lobe epilepsy. Neurology, 53: 1882-1885
81. RYVLIN P. (2003) Beyond pharmacotherapy: surgical management. Epilepsia, 44: 23-28.
82. RYVLIN P, KAHANE P, ISNARD J, et al. (2001). Temporal plus epilepsies II: Surgical results. Epilepsia, 42: 198.
83. RYVLIN P, MAUGIÈRE F. (2001). Les explorations neuro-fonctionnelles dans une stratégie préchirurgicale des epilepsies rebelles. Annales Françaises d'Anesthésie- Réanimation, 20: 123-136.
84. SABSEVITZ DS, SWANSON SJ, HAMMEKE TA, et al. (2003) Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery. Neurology, 60: 1788-1792.
85. SABSEVITZ DS, SWANSON SJ, MORRIS GL, MUELLER WM, SEIDENBERG M. (2001) Memory outcome after left anterior temporal lobectomy in patients with expected and reversed Wada memory asymmetry scores. Epilepsia, 42: 1408-1415.
86. Sadzot B, Debets RMC, Maquet P, et al. (1992). Regional brain glucose metabolism in patients with complex partial seizures investigated by intracranial EEG. Epilepsy Res, 12: 121-129.
87. SALANOVA V, MARKAND O, WORTH R. (2001) Focal functional deficits in temporal lobe epilepsy on PET scans and the intracarotid amobarbital procedure: comparison of patients with unitemporal epilepsy with those requiring intracranial recordings. Epilepsia, 42: 198-203.
88. SAVIC I, SVANBORG E, THORELL JO. (1996). Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia, 37: 236-244.
89. SHIN WC, HONG SB, TAE WS, KIM SE. (2002). Ictal hyperperfusion patterns according to the progression of temporal lobe seizures. Neurology, 58: 373-380.
90. SIGNORINI M, PAULESU E, FRISTON K, et al. (1999). Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage, 9: 63-80.
91. SWARTZ BE, BROWN C, MANDELKERN MA, et al. (2002). The use of 2-deoxy-2-[18F]fluoro-D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol, 4: 245-252.
92. SZELIES B, WEBER-LUXENBURGER G, MIELKE R, et al. (2000). Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry. Eur J Neurol, 7: 393-400.
93. SZELIES B, SOBESKY J, PAWLIK G, MIELKE R, BAUER B, HERHOLZ K, HEISS WD. (2002). Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET. Eur J Neurol, 9: 137-42.
94. THEODORE WH, SATO S, KUFTA C, BALISH MB, BROMFIELD EB, LEIDERMAN DB. (1992a). Temporal lobectomy for uncontrolled seizures: The role of positron emission tomography. Ann Neurol, 32: 789-794.
95. THEODORE WH, SATO S, KUFTA CV, GAILLARD WD, KELLEY K. (1997). FDG-positron emission tomography and invasive EEG: seizure focus detection and surgical outcome. Epilepsia, 38: 81-86.
96. THEODORE WH, GAILLARD WD, DE CARLI C, BHATIA S, HATTA J. (2001). Hippocampal volume and glucose metabolism in temporal lobe epileptic foci. Epilepsia, 42: 130-132.
97. THEODORE WH. (2002). When is positron emission tomography really necessary in epilepsy diagnosis? Curr Opin Neurol, 75:191-195. Review.
98. VAN BOGAERT P, MASSAGER N, TUGENDHAFT P, et al. (2000). Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage, 12: 129-138.
99. VAN PAESSCHEN W, DUPONT P, VAN DRIEL G, VAN BILLOEN H, MAES A. (2003). SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain, 126: 1103-1111.
100. VIELHABER S, VON OERTZEN JH, KUDIN AF, et al. (2003). Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy. Epilepsia, 44: 193-199.
101. WEIL S, NOACHTAR S, ARNOLD S, YOUSRY TA, WINKLER PA, TATSCH K. (2001). Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control. Nucl Med Commun, 22: 233-237.
102. WOERMANN FG, JOKEIT H, LUERDING R, et al. (2003) Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology, 61: 699-701.
103. WUNDERLICH G, SCHULLER MF, EBNER A, HOLTHAUSEN H, TUXHORN I, WITTE OW, SEITZ RJ. (2000). Temporal lobe epilepsy with sensory aura: interictal glucose hypometabolism. Epilepsy Res Feb, 8: 139-149.